227 filings
Page 2 of 12
8-K
q3tarq0p
12 Aug 22
Departure of Directors or Certain Officers
4:34pm
8-K
ztnrbkopsalzm
9 Aug 22
NeoGenomics Reports Revenue of $125 Million in the Second Quarter
7:05am
8-K
cae7x8ev3
21 Jul 22
NeoGenomics Announces Chief Executive Officer Appointment
4:41pm
8-K/A
0ahmgna5
18 Jul 22
Departure of Directors or Certain Officers
4:31pm
8-K
3nfjkfwoomg 9514az5
3 Jun 22
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
ws3xw
16 May 22
NeoGenomics Appoints Lynn Tetrault Interim CEO
10:13am
8-K
7p78 t2c1d
11 May 22
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
5:02pm
8-K
7uo9un9u2ru9eo9 qg
6 May 22
Departure of Directors or Certain Officers
4:34pm
8-K
mf5k8wo4xw8r 45ju
27 Apr 22
NeoGenomics Reports Revenue of $117 Million in the First Quarter
7:19am
8-K
lksuu7 xlb18
25 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
iu690f
14 Apr 22
Other Events
4:23pm
8-K
j8caal8xcine wakq4
28 Mar 22
NeoGenomics Announces CEO Departure and Initiates CEO Search
4:20pm
8-K
2h8orma9mtclduh6
9 Mar 22
Departure of Directors or Certain Officers
8:57am
8-K
067po
23 Feb 22
NeoGenomics Reports Full Year Revenue of $484 Million and Fourth Quarter Results
7:14am
8-K
vp7dwnf5pqipkzmj5bs
19 Jan 22
Departure of Directors or Certain Officers
4:27pm
8-K
pq0962
10 Nov 21
Departure of Directors or Certain Officers
5:06pm
8-K
p2if y7vp
4 Nov 21
NeoGenomics Reports Revenue of $121 Million
7:23am
8-K
iybuwv084lipg9
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K/A
3amnsfuhjs764xi
1 Sep 21
Consolidated financial statements
4:34pm
8-K
4c86xp
10 Aug 21
Regulation FD Disclosure
5:09pm